Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Year-ahead forecast
Pharma
2023 forecast: FDA revamps cancer drug approvals
SVB's Daina Graybosch foresaw a “massive delay” in cancer drug approvals as companies try to shift gear and adjust their regulatory timeline.
Angus Liu
Dec 21, 2022 5:00am
Novo's Wegovy faces pivotal 2023 as Lilly's tirzepatide homes in
Dec 21, 2022 5:00am
AI tools are finally changing the biopharma landscape
Dec 21, 2022 5:00am
Forecast 2023: The biopharma name changing craze
Dec 19, 2022 5:00am
2022 forecast: FDA surveillance in pandemic year 3
Dec 22, 2021 10:25am
2022 forecast: Biopharma's COVID response next year
Dec 22, 2021 10:15am
